Rite Aid is reportedly planning to file for bankruptcy to address federal and state lawsuits it is facing over its alleged role in the sale of opioids, per a WSJ report.
Rite Aid is reportedly preparing to file for bankruptcy in the coming weeks to address federal and state lawsuits it is facing over its alleged role in the sale of opioids, according to a Wall Street Journal report, which cited people familiar with the plan.
The Chapter 11 filing would cover Rite Aid’s more than $3.3 billion debt load and pending legal allegations that it oversupplied prescription painkillers, according to the report.
Rite Aid did not immediately respond to a Drug Store News (an EnsembleIQ brand and sister publication of Progressive Grocer) request for comment.
[Read more: "Rite Aid Hit With Class Action for Allegedly Sharing Customer Data With Meta"]
Rite Aid operates more than 2,330 stores in 17 U.S. states.
The retailer has been named a defendant in lawsuits that alleged they helped fuel the opioid crisis in the United States. The U.S. Department of Justice in March sued Rite Aid, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids, according to a Reuters report, which also noted that Rite Aid also is facing lawsuits over opioids by state and local governments around the country. Other pharmacies, drugmakers and distributors have reached nationwide settlements of similar claims totaling more than $50 billion.
Rite Aid has not reached any nationwide settlement, though it has struck some smaller deals including a $10.5 million agreement with several counties last year, the report said.
[Read more: "Rite Aid Opens 4th Small-Format Store in Rural Virginia"]
Headquartered in Philadelphia, Rite Aid employs more than 6,300 pharmacists. The drug store chain is No. 22 on The PG 100, Progressive Grocer’s 2023 list of the top food and consumables retailers in North America.
This article first appeared on the site of sister publication Drug Store News.